Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.05M Buy
29,711
+3,184
+12% +$391K 0.05% 510
2026
Q1
$3.13M Buy
26,527
+21,379
+415% +$2.99M 0.05% 536
2025
Q4
$844K Buy
+5,148
New +$806K 0.02% 1152
2025
Q3
Sell
-17,352
Closed -$2.16M 3152
2025
Q2
$2.16M Buy
17,352
+4,417
+34% +$562K 0.09% 299
2025
Q1
$1.65M Buy
12,935
+3,295
+34% +$507K 0.08% 324
2024
Q4
$1.39M Buy
+9,640
New +$1.38M 0.11% 164
2023
Q4
Sell
-5,515
Closed -$877K 2039
2023
Q3
$877K Buy
5,515
+1,139
+26% +$186K 0.15% 138
2023
Q2
$619K Sell
4,376
-289
-6% -$46.3K 0.11% 252
2023
Q1
$785K Buy
+4,665
New +$832K 0.16% 101
2022
Q4
Sell
-2,859
Closed -$535K 1449
2022
Q3
$535K Buy
+2,859
New +$603K 0.13% 215

Other funds holding RGEN

XTX Topco's RGEN Position: Q2 2026 in Review

XTX Topco increased its Repligen (RGEN) stake by 12% in Q2 2026, buying an estimated $391K and bringing the position to 29,711 shares worth $4.05M. The position accounts for 0.05% of the portfolio, ranked #510.

XTX Topco first reported a position in RGEN in Q3 2022 and has held it in 10 quarters since. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • XTX Topco held 29,711 shares of Repligen worth $4.05M as of Q2 2026.
  • XTX Topco bought 3,184 Repligen shares in Q2 2026, an estimated $391K.
  • Repligen made up 0.05% of XTX Topco's portfolio in Q2 2026, its #510 holding.
  • XTX Topco first reported a position in Repligen in Q3 2022 and has held it in 10 quarters since.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.